Thursday, February 27, 2025
HomeIndustriesHealthcare

Healthcare

Lumeris Names Dr. David Carmouche EVP & Chief Clinical Transformation Officer

Lumeris, a value-based care transformation leader, announced the appointment of David Carmouche, MD, as executive vice president and chief clinical transformation officer. Carmouche will be...

NanoVation & Novo Nordisk Team Up on Genetic Medicines

NanoVation Therapeutics, a platform company developing innovative technologies to overcome the barriers of nucleic acid delivery, announced a multi-year partnership with Novo Nordisk to...

DaVita Appoints David Maughan New Chief Operating Officer

DaVita, a leading provider of kidney care services, announced that David Maughan will assume the role of chief operating officer. This appointment builds on...

Read Magazine’s Weekly News Roundup With Cyberhawk, Nuro, Switch Bioworks, Protege , Polyplastics, Teledyne, And More!

Here is Read Magazine’s Weekly Roundup of the top news from global markets. In this fast-paced world, breaking down information helps readers grasp the...

OrsoBio Secures $67M Series B for Mitochondrial Obesity Treatments

OrsoBio, Inc, a clinical-stage biopharmaceutical company developing treatments for obesity and obesity-associated disorders, announced the close of an oversubscribed $67 million Series B financing....
0FansLike
0FollowersFollow
spot_img

Hot Topics